Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Tokyo Big Sight

Nov 10, 2019 9:30 AM - Nov 12, 2019 5:40 PM

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

16th DIA Japan Annual Meeting 2019

Delivering Rational Medicine for All People in the Globe

Student Session: Medical Risk Communication on Diabetes Medicine: What Information Should We Share?

Session Chair(s)

Mikako  Einaga

Mikako Einaga

Student, Department of Organic and Bioorganic Chemistry

Showa University, School of Pharmacy, Japan

Minami  Mori

Minami Mori

CRA, Clinical Operations

IQVIA Services Japan K.K., Japan

Toshiaki  Suga

Toshiaki Suga


Nihon University, Japan

Yuki  Sugao

Yuki Sugao

Tokyo University of Pharmacy and Life Science, Japan

No medication can be taken without any risk. Therefore, medical risk communication, the process of sharing medical risk information and of filling the gap of understanding of a medication between healthcare providers and others (especially patients) is an essential step not only for doctors but for everyone. This session stresses the importance of risk communication to future medical professionals by examining the SGLT2 inhibitor diabetes medicine. After the lecture segment of this session, participants will discuss in groups what risk information should be shared, with whom, and how.


Michiko  Yamamoto, PhD

Fundamentals and Practical Applications of Risk Communication on Medicines

Michiko Yamamoto, PhD

Kumamoto University, Japan

Visiting Professor

Kasumi  Daidoji, PhD, RPh

Student Session

Kasumi Daidoji, PhD, RPh

Eisai Co., Ltd., Japan

Associate Director, Clinical Planning & Development Dept., Medical Headquarters

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.